SCM
FATE icon

Sterling Capital Management’s Fate Therapeutics FATE Stock Holding History

Sterling Capital Management’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.32K Sell
3,600
-2,668
-43% -$3.25K ﹤0.01% 2793
2025
Q4 		$6.16K Sell
6,268
-1,236
-16% -$1.48K ﹤0.01% 2819
2025
Q3 		$9.46K Buy
7,504
+4,676
+165% +$5.04K ﹤0.01% 2509
2025
Q2 		$3.17K Buy
2,828
+1,029
+57% +$1.2K ﹤0.01% 2758
2025
Q1 		$1.42K Sell
1,799
-1,601
-47% -$1.96K ﹤0.01% 2697
2024
Q4 		$5.61K Buy
3,400
+3,048
+866% +$7.68K ﹤0.01% 2420
2024
Q3 		$1.23K Buy
+352
New +$1.37K ﹤0.01% 2425
2015
Q4 		– Sell
-29,823
Closed -$159K – 998
2015
Q3 		$159K Sell
29,823
-10,897
-27% -$74.4K ﹤0.01% 929
2015
Q2 		$263K Buy
+40,720
New +$244K ﹤0.01% 817

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return